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Abstract
Background: Cataract surgery typically offers instant visual rehabilitation with rare postoperative complications.
However, if complications occur, these complications may be confusing and threatening. We present a case of
severe bilateral panuveitis following phacoemulsification and intraocular lens implantation and discuss the
importance of a correct diagnosis and management.
Case presentation: A 75-year-old Asian male with bilateral phacoemulsification and intraocular lens implantation
developed severe inflammation with sharp vision loss in both eyes after the surgeries. Physical examination indicated
bilateral panuveitis. With a presumptive diagnosis of suppurative endophthalmitis and a history of effective treatment
with intravenous antibiotics plus ofloxacin and steroid drops, intravenous ceftazidime and vancomycin were
administered. However, the effects were minimal. With a supplemental history of recurrent oral, perineal, and
gastrointestinal ulcers, a diagnosis of Behcet’s disease was made, and systemic immune inhibitors were prescribed
instead of invasive treatments, which might exacerbate the condition. After 5 days of medication, the inflammation
was markedly relieved, and no recurrence was observed 2 weeks later.
Conclusion: Correct differentiation of confusing conditions is crucial to implement appropriate management.
Postoperative complications of cataract surgery should be differentiated carefully, and perioperative management in
patients with autoimmune uveitis should be provided with caution.
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Background
Cataract surgery typically obtains instant visual re-
habilitation and is extensively performed today. Given
the surgery’s effectiveness and high safety profile, both
patients and ophthalmic surgeons have high expecta-
tions for the outcome. Thus, serious postoperative
complications threatening visual acuity have attracted
considerable attention from both surgeons and patients.
Correct differentiation of confusing conditions is cru-
cial to implement the appropriate management. We
present a case of serious bilateral panuveitis following
uncomplicated phacoemulsification and intraocular lens
(IOL) implantation in an elderly male and discuss the
importance of a correct diagnosis and management.
Case presentation
A 75-year-old man was admitted to our hospital emer-
gently with a presumptive diagnosis of suppurative en-
dophthalmitis after bilateral cataract surgery in another
hospital. The perioperative history of the cataract sur-
gery was reviewed. This patient had bilateral blurred vi-
sion for 2 years. No anterior inflammation was
reported preoperatively. The fundus “could not be ob-
served by ophthalmoscopy.” Optical coherence tomog-
raphy (OCT) revealed epimacular membrane and local
serous neuroepithelial detachment in the left eye (Fig. 1);
ultrasound revealed bilateral vitreous opacity. After un-
eventful phacoemulsification and IOL implantation in
both eyes, visual acuity (VA) values were 0.2 (right) and
0.3 (left). No keratic precipitates (KP) or aqueous flare was
noted, but mild opacity in vitreous was observed. Postop-
erative antibiotics and steroid drops were prescribed for
1 month. Five weeks after the first surgery (the right eye),
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he suffered sharp vision loss, hand motion (HM), in the
right eye with severe panuveitis and was diagnosed with
endophthalmitis. After a week of intravenous levofloxacin
and cefazolin plus ofloxacin and steroid drops, the VA re-
covered to 0.15 with little anterior chamber reaction. Two
months later, the left eye underwent a similar pattern.
Again, the condition was diagnosed and treated in a simi-
lar manner. Remission was obtained 1 week later. After re-
current inflammatory episodes in both eyes over a 6-
month period, he presented at our emergency department.
The VA was HM in both eyes. Intraocular pressure (IOP)
values were 6 mmHg in the right eye and 4 mmHg in the
left eye. Both eyes exhibited deep ocular redness, corneal
edema, a few cells and non-granulomatous KP, 2 mm
hypopyon, aqueous flare (++), and iris neovascularization
(Fig. 2a). The fundus was not visible due to vitreous in-
flammation. Ultrasound examination revealed bilateral vit-
reous opacity. According to his history, intravenous
ceftazidime and vancomycin plus ofloxacin and steroid
drops were administered. However, after 2 days, inflam-
mation remained severe and unchanged.
Based on the uncontrolled inflammatory reaction, in-
vasive treatments, including intracameral or intravitreal
injections, and even vitrectomy, were considered. We
then learned from the patient’s daughter that he suf-
fered from recurrent moderately painful oral, perineal,
and gastrointestinal ulcers for many years, which were
relieved by long-term corticosteroid treatment. The
daughter and the patient denied ocular complaints in
the years prior to his surgery. Due to the possibility of
autoimmune uveitis, which might be induced by ocular
surgery, invasive operations such as anterior chamber
paracentesis or vitreous tap were delayed to avoid further
reactive inflammation and possible iatrogenic infection. A
panel of immunology tests and an etiological examination
were conducted and revealed no significant abnormality.
However, based on the typical oral and perineal signs and
the ocular attack, a diagnosis of Behcet’s disease was
made. Oral prednisone, thalidomide and cyclophospha-
mide were attempted before any invasive treatment. After
5 days, the inflammation was markedly reduced (Fig. 2b).
The inflammation was invisible at his last visit 2 weeks
Fig. 1 Optical coherence tomography (OCT) demonstrated epimacular membrane (white arrows) and local serous neuroepithelial detachment
(red arrows) in the left eye
Fig. 2 a Prior to immunosuppressive therapy, the left eye had deep
ocular redness, corneal edema, 2-mm hypopyon (red arrows) and iris
neovascularization (black arrows). However, the hypopyon was relatively
quiet with few cells and little aqueous flare. b After immunosupressive
therapy, the anterior chamber reaction was obviously reduced in the left
eye, and the hypopyon was completely absorbed 5 days after oral
prednisone, thalidomide and cyclophosphamide were added
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later, after which he returned to his hometown and did
not return for further evaluation.
Discussion
Differentiation of complications after cataract surgery
Cataract surgery is a relatively safe procedure that typically
provides immediate improvement in vision [1]. However,
serious complications can occur, including infectious en-
dophthalmitis, toxic anterior segment syndrome (TASS),
[2] and sympathetic ophthalmia (SO) [3]. For some pa-
tients with systemic immunological conditions, such as
Behcet’s disease in this case, uveitis induced by surgery
should be expected [4]. In addition, Masquerade syn-
drome [5] may be considered in elderly patients. With
similar signs and symptoms, these conditions could be
confusing to surgeons. For infectious endophthalmitis, in-
vasive procedures, such as intracameral and intravitreal
injections or vitrectomy, are typically performed. However,
for SO and autoimmune uveitis, additional surgery may
exacerbate the inflammation.
In this case, the effective treatment history could be
misleading. Endophthalmitis might be considered first
due to its higher incidence had his past oral and peri-
neal ulcer history not been known. However, there were
other clues to guide us: (1) the long interval between
surgery and inflammation occurrence, greater than
1 month; (2) the feature of repeated occurrence during
a long course of 6 months; (3) the resistance to anti-
biotic treatment; (4) the very low IOP, 6 mmHg (right)
and 4 mmHg (left), argued against acute infection; and
(5) the fewer cells and less aqueous flare in anterior
chamber compared with severe infection. All of these
signs suggest that noninfectious inflammation should
be taken into account. TASS could be easily excluded
due to the long interval between the surgery and in-
flammation. Treatments for SO and Behcet’s disease
are similar. For Masquerade syndrome, vitreous biopsy
and cytological tests could be indicative; however, these
procedures are invasive and dangerous to this patient.
In our case, given the effectiveness of immunosupres-
sive therapy, Masquerade syndrome could be excluded.
A limitation in our case is that only short-term follow-
up was possible, and such patients require long-term
follow-up to fully evaluate the outcome and potential
recurrence.
Perioperative management of cataract surgery in Behcet’s
disease and other uveitis
Studies revealed good vision prognosis for cataract surgery
in patients with Behcet’s disease if no active inflammation
occurred for 3 months before surgery [6]. In this case, the
man did not reveal past ocular history, and no inflamma-
tion was observed prior to surgery. Thus, it reminded us
that the perioperative management of cataract surgery in
such patients should be performed with greater caution.
(1) Autoimmune disease history, including oral and skin
ulcers and arthralgia, should be included in history-taking.
(2) Physical examination and interpretation of auxiliary
tests should be carefully performed. Reviewing his peri-
operative record, we noticed that the preoperative ultra-
sound revealed bilateral vitreal opacity, and OCT
demonstrated epimacular membrane and local serous
neuroepithelial detachment in the left eye, which could be
indicative of long-term chronic inflammation. Combined
with the history, some threatening conditions might be
suggested. (3) Uveitis should be inactive for at least
3 months preoperatively, and anti-inflammation therapy
should be used preoperatively and continued postopera-
tively [7]. (4) Even if the awareness of autoimmune disease
might have been lacking prior to surgery, these condi-
tions should be taken into routine consideration, just
like infectious inflammation, in postoperative follow-
up. This would help achieve correct differentiation and
treatment of postoperative complications.
Conclusion
The management of patients with cataract in combin-
ation with uveitis is complicated. Once postoperative
complications occur, these conditions may be confusing
and threatening. Thus, the perioperative management of
cataract surgery in such patients should be performed
with great care.
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